EUVIMEDEUVIMED entdecken
Systematische Übersicht

Abstract 1178: Endovascular Therapy versus Best Medical Therapy for Distal Medium Vessel Occlusion Stroke, A Meta Analysis and Systematic Review.

M. A. Amer, A. Aljabali, A. Ghazou, M. Jaradat, H. Zeitoon, N. Madhav, M. Mustafa, M. Almajali, C. Rupareliya, Y. Imam, J. Tarsia

Stroke: Vascular and Interventional Neurology · 18.10.2026 · 6 (Suppl_1)

DOI: 10.1161/svi270000_1178 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Stroke: Vascular and Interventional Neurology, erschienen am 18.10.2026. Verfasst von M. A. Amer und 10 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The efficacy and safety of endovascular therapy (EVT) for acute ischemic stroke due to distal medium vessel occlusion (DMVO) remain uncertain. We performed a systematic review and meta-analysis of randomized controlled trials (RCTs) to determine whether EVT confers clinical benefit over medical management (MM) alone.

Method

This PROSPERO-registered review (CRD420261483890) adhered to PRISMA methodology. PubMed/MEDLINE, Embase, Scopus, the Cochrane Central Register of Controlled Trials (CENTRAL), and ScienceDirect were systematically interrogated from inception through August 2026 for randomized controlled trials comparing endovascular thrombectomy (EVT) with medical management (MM) for acute ischemic stroke attributable to distal/medium-vessel occlusion (DMVO; MCA M2-M4, ACA A1-A3, or PCA P1-P3). Given trial-level heterogeneity in M2 eligibility, both dominant and non-dominant M2 occlusions were included in our analysis; with M2 classification prespecified for subgroup analysis. Co-primary endpoints were 90-day excellent functional outcome (mRS 0-1) and functional independence (mRS 0-2); secondary endpoints comprised mortality, symptomatic intracranial hemorrhage, and any intracranial hemorrhage. Risk ratios (RRs) with 95% CIs were synthesized using DerSimonian-Laird random-effects models, with heterogeneity quantified by I². Methodological bias was adjudicated using Cochrane RoB 2.

Results

Four RCTs (n=1,879; EVT 929, medical management 950) were included (ORIENTAL-MeVO, ESCAPE-MeVO, DISTAL, DISCOUNT). EVT did not significantly improve 90-day excellent functional outcome (RR 1.11, 95% CI 0.99-1.24; P=0.07; I²=75%) or functional independence (RR 1.04, 95% CI 0.96-1.12; P=0.37; I²=69%), with substantial intertrial heterogeneity driven by benefit confined to ORIENTAL-MeVO. Mortality was comparable (RR 1.15, 95% CI 0.90-1.48; P=0.26). Conversely, EVT significantly increased symptomatic intracranial hemorrhage (RR 2.54, 95% CI 1.58-4.10; P

Zitieren

APA

Amer, M. A., Aljabali, A., Ghazou, A., Jaradat, M., Zeitoon, H., Madhav, N., Mustafa, M., Almajali, M., Rupareliya, C., Imam, Y., & Tarsia, J. (2026). Abstract 1178: Endovascular Therapy versus Best Medical Therapy for Distal Medium Vessel Occlusion Stroke, A Meta Analysis and Systematic Review. Stroke: Vascular and Interventional Neurology, 6(Suppl_1). https://doi.org/10.1161/svi270000_1178

Vancouver

Amer MA, Aljabali A, Ghazou A, Jaradat M, Zeitoon H, Madhav N, et al. Abstract 1178: Endovascular Therapy versus Best Medical Therapy for Distal Medium Vessel Occlusion Stroke, A Meta Analysis and Systematic Review. Stroke: Vascular and Interventional Neurology. 2026;6(Suppl_1). doi:10.1161/svi270000_1178

BibTeX
@article{Amer2026,
  author = {Amer, M. A. and Aljabali, A. and Ghazou, A. and Jaradat, M. and Zeitoon, H. and Madhav, N. and Mustafa, M. and Almajali, M. and Rupareliya, C. and Imam, Y. and Tarsia, J.},
  title = {Abstract 1178: Endovascular Therapy versus Best Medical Therapy for Distal Medium Vessel Occlusion Stroke, A Meta Analysis and Systematic Review},
  journal = {Stroke: Vascular and Interventional Neurology},
  year = {2026},
  volume = {6},
  number = {Suppl_1},
  doi = {10.1161/svi270000_1178}
}
Kostenlos starten →